House Plans Suspension Vote On Lower Costs, More Transparency Act

By Michelle M. Stein / December 5, 2023 at 7:49 PM
The Lower Costs, More Transparency Act is once again on the House’s schedule to be voted on under suspension of the rules, during the week of Dec. 11, amid repeated calls from hospital site-neutral pay reform proponents for lawmakers to act before the end of the year and while stakeholders prep for a possible health package early next year. The House tri-committee package of pharmacy benefit manager reforms, provider price transparency, hospital drug administration site-neutral pay and extenders was unveiled...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.